WO2025185741 - GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC GENES
National phase entry is expected:
Publication Number
WO/2025/185741
Publication Date
11.09.2025
International Application No.
PCT/CN2025/081345
International Filing Date
07.03.2025
Title **
[English]
GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC GENES
[French]
ANIMAL NON HUMAIN GÉNÉTIQUEMENT MODIFIÉ EXPRIMANT DES GÈNES HUMAINS OU CHIMÉRIQUES
Applicants **
BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD.
Inventors
WANG, Linlin
LV, Ruili
FU, Shaozu
ZHANG, Meiqi
GUO, Jing
Priority Data
202410266881.5
08.03.2024
CN
202410742436.1
07.06.2024
CN
202411131695.7
16.08.2024
CN
202411426464.9
12.10.2024
CN
202510094101.8
21.01.2025
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 6094 | |
| EPO | Filing, Examination, Granting | 133750 | |
| Japan | Filing, Examination, Granting | 4980 | |
| South Korea | Filing, Examination, Granting | 9487 | |
| USA | Filing, Examination, Granting | 40640 |
Total:
194,951
Contact Us
Abstract[English]
Provided are genetically modified non-human animals that express human or chimeric (e.g., humanized) IL12RB1, IL12RB2, and/ or IL23R, and methods of use thereof.[French]
L'invention concerne des animaux non humains génétiquement modifiés exprimant IL12RB1, IL12RB2, et/ou IL23R humains ou chimériques (par exemple, humanisés), et leurs procédés d'utilisation.